KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 72 filers reported holding KALA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $5,325,000 | -45.6% | 506,647 | -54.5% | 0.34% | -62.9% |
| Q1 2020 | $9,796,000 | +299.3% | 1,114,520 | +67.7% | 0.91% | +411.9% |
| Q4 2019 | $2,453,000 | +34.9% | 664,641 | +39.0% | 0.18% | +7.9% |
| Q3 2019 | $1,819,000 | -4.1% | 478,206 | +60.9% | 0.16% | -5.7% |
| Q2 2019 | $1,897,000 | -33.6% | 297,250 | -13.9% | 0.17% | -36.7% |
| Q1 2019 | $2,856,000 | +31.1% | 345,346 | -22.5% | 0.28% | +1.5% |
| Q4 2018 | $2,178,000 | +130.7% | 445,516 | +365.8% | 0.27% | +222.6% |
| Q3 2018 | $944,000 | -79.5% | 95,655 | -71.5% | 0.08% | -71.4% |
| Q2 2018 | $4,609,000 | +1326.9% | 335,624 | +1544.5% | 0.29% | +425.0% |
| Q1 2018 | $323,000 | – | 20,409 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vahanian & Associates Financial Planning Inc. | 1,046,484 | $1,266,000 | 1.02% |
| RA Capital Management | 10,874,613 | $13,158,000 | 0.23% |
| Samsara BioCapital, LLC | 601,162 | $727,000 | 0.14% |
| Matisse Capital | 41,400 | $50,000 | 0.04% |
| Manteio Capital LLC | 19,546 | $24,000 | 0.03% |
| Covestor Ltd | 17,766 | $21,000 | 0.03% |
| Knights of Columbus Asset Advisors LLC | 241,857 | $293,000 | 0.02% |
| Virtu Financial LLC | 126,231 | $153,000 | 0.02% |
| Aquatic Capital Management LLC | 6,200 | $8,000 | 0.02% |
| CAXTON CORP | 13,155 | $16,000 | 0.01% |